ReviewCureus2022

Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review.

Hameeda Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.